Cajal Neuroscience

Home — Cajal Therapeutics

Seattle, United States · Founded 2020 · $96.0M raised

Founded
2020
Business Model
B2B
Total Funding
$96.0M
Last Round
$96.0M Series ANov 2022
Rounds
1

About

Cajal Neuroscience is a Seattle-based biotechnology company integrating human genetics, functional genomics, and advanced microscopy to discover novel targets and therapeutics for neurodegeneration. Founded in 2021, the company applies computational biology and high-throughput functional validation to understand the mechanistic, spatial, and temporal complexity of neurodegenerative diseases.

Summary

Cajal Neuroscience is a Biotech company based in Seattle, United States, founded in 2020. It has raised $96.0M in total across 1 round, most recently a $96.0M Series A round in Nov 2022. Investors include The Column Group, Lux Capital and Two Sigma Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ANov 2022
$96.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cajal Neuroscience on Indexed.vc
<a href="https://indexed.vc/companies/cajal-neuroscience"><img src="https://indexed.vc/api/badge/company/cajal-neuroscience" alt="Cajal Neuroscience on Indexed.vc" width="260" height="76" /></a>